Surveying The CRISPR Patent War

By Michael Stramiello (May 3, 2018, 12:56 PM EDT) -- Following this week's oral argument at the U.S. Court of Appeals for the Federal Circuit, there has been a surge of interest in the long-running CRISPR[1] patent dispute between the Regents of the University of California (with collaborators the University of Vienna and Emmanuelle Charpentier) and the Broad Institute (with collaborators Harvard and MIT). This article summarizes the broader patent war between those two sides and addresses its potential implications for others seeking to use CRISPR-based technologies....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!